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Biochemical  evidence  for  protein  synthesis  on 
nuclear  ribosomes  has  accumulated  in  several 
laboratories in recent years (1, 2, 5). The morpho- 
logic sites of this activity in the intact mammalian 
cell,  in  particular  the  respective  roles  of the  nu- 
cleolus  and  chromosomes  in  nucleoprotein  and 
nucleic acid synthesis, remain  unclear (6-12). 
A  quantitative  autoradiographic  and  cyto- 
chemical  study  of  this  question  has  been  reat- 
tempted  by comparing  the relative uptake  of H 3- 
lysine and H3-uridine or HS-cytidine in  untreated 
HeLa  cells with  that  in  cells in  which  nucleolar 
RNA  synthesis  was  selectively inhibited  by  low 
concentrations of Actinomycin D  according to the 
method  of Perry  (13).  In  parallel,  some  cellular 
sites of e-amino groups were stained with Biebrich 
scarlet (14,  15). 
It was found that lysine is rapidly incorporated 
into  a  nucleolar  material  solubilized  either  by 
agents  which  hydrolyze  RNA  or  by  the  proteo- 
lytic  enzyme  trypsin.  This  incorporation  is  in- 
hibited by concentrations of Actinomycin D  which 
also  selectively inhibit  the  synthesis  of nucleolar 
RNA; but lysine incorporation  is not inhibited in 
extranucleolar  chromatin  and  cytoplasm.  When 
stained for basic protein with Biebrich scarlet under 
selective conditions  of fixation,  nucleoli  Showing 
lysine incorporation  present a  characteristic gran- 
ular  substructure  not  exhibited,  or  severely  al- 
tered,  in  actinomycin-treated  cells  (16)  and  in 
cells treated under  conditions of RNA extraction. 
MATERIALS  AND  METHODS 
Hela cells  1 grown in Leighton tubes,  maintained  in 
Eagle's  medium  (17)  supplemented  by  10  per  cent 
horse serum,  were labeled in growth phase for 5  or 
15  minutes  with  Ha-lysine  (164.5  mc/mmole  ~,  10 
/zc/rnl) in Eagle's medium lacking lysine,  and  with 
HS-uridine  (2.60  c/mmole,  10 btc/ml)  or HS-cytidine 
(2.52  c/mmole, 10 gc/ml)) 
The cells were washed 5 times in Hanks' balanced 
salt solution and  fixed for  30 minutes  at 0°C in 3.7 
per  cent  formaldehyde  (Fisher  Scientific Company, 
New York, certified reagent) in Millonig's phosphate 
buffer  (18)  at pH 7.3.  The cells were washed  3 to 5 
times in cold distilled water,  followed by  1 per cent 
perchloric  acid at  0-4°C for  30  minutes,  and  again 
washed 3 to 5 times in cold distilled water, then air- 
dried and coated with liquid autoradiographic emul- 
sion  (Kodak  NTB-3,  diluted  l:l)  according  to 
standard  techniques.  The exposure times at  --20°C 
were selected so that approximately the same nuclear 
grain counts were obtained with H3-1ysine (26 days) 
as with H3-uridine or H3-cytidine (6 days). The auto- 
radiographs were developed in Ficq's diaminophenol 
developer  (19)  and  stained  through  the  emulsion 
with Harris' hematoxylin and eosin. 
The relative uptakes of lysine and RNA precursor 
over the  nucleolus,  chromatin,  and  cytoplasm were 
then determined by mean grain count of groups of 20 
technically clear, randomly selected cells and by com- 
parison of the mean  of the ratios of nucleolar to total 
a Horse  serum  adapted,  obtained  from  Micro- 
biological Associates,  Bethesda. 
2 Radioehemical  Centre,  Amersham,  England. 
3 New  England  Nuclear  Corporation,  Boston. 
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FmUR~  1  Effect  of  concentration  of 
Actinomyein D  on  mean  nuclear  and 
nucleolar grain count of groups of gO HeLa 
cells  labeled with  H3-1ysine and  H3-uri  - 
dine. 
nuclear counts.  Grain counts were made at least in 
triplicate with the aid of an ocular micrometer grid 
(0.25  ram2)  and a  Zeiss apochromatic  100/1.32  ob- 
jective. The ratio of volumes of nucleolus to nucleus 
was approximated by the ratio of areas calculated as 
idealized rectangles. 
Before  labeling,  some  cells  were  pretreated  with 
Actinomycin  D 4  (0.05  to  1.0  #g/mi)  for  3  hours 
followed in most experiments by a  "chase" in main- 
tenance medium for 3 to 4 hours (13). 
Extraction  and  hydrolysis  procedures  for  basic 
proteins  and  nucleic  acids  were  carried  out  with 
0.5 N HC104 and with 0.2 N HCI for 30 to 60 minutes 
at 25 ° and 0°C (20), with 1 N HC1 at 60°C for l0 min- 
utes  as  in  the  Feulgen  procedure,  and  with  0.3  N 
trichloracetic acid at 90°C for 30 minutes. 
Enzymatic  digestion  was  performed  with:  (a) 
Ribonuclease,  (5  times  crystallized,  Worthington 
Biochemicals  Corp.,  Freehold,  New  Jersey  and 
Pentex Inc., Kankakee, Illinois)  1 mg/ml in 0.016  m 
sodium phosphate buffer (McIlvaine), at pH 7.0 for 
60 minutes at 37°C.  (b) Desoxyribonuclease, (Sigma 
Chemical  Company,  St.  Louis,  1 time crystallized) 
0.5  mg/ml  in  0.002  ~  tris(hydroxymethyl)amino- 
methane  (Sigma  121, Sigma  Chemical  Company), 
0.005  M CaC12 and 0.45  M MgC12 at  pH  7.3  for 60 
minutes at 37°C.  (c) Trypsin, (Fisher Scientific Corn- 
4 Kindly  supplied  by  Merck,  Sharpe  &  Dohme 
Co., West Point, Pennsylvania. 
pany,  Nutritional  Biochemicals Corporation,  Cleve- 
land) 0.5 mg/ml in distilled water adjusted to pH 6.5 
at 0°C for 30 minutes (21). 
Control cells were stained with Biebrich scarlet at 
pH 9.5  in 0.5  N glycine buffer  (14)  after controlled 
fixation and partial deamination as above. 
RESULTS 
As  previously  observed  (22)  uptake  of  tritiated 
lysine,  unlike  nucleosidc label,  occurs  rapidly  in 
both cytoplasm and  nucleus of HcLa cells, a  fact 
which  complicates  dynamic  studies  of  localiza- 
tion.  Comparison  with  RNA  precursors  shows 
parallel  lysinc labeling over the nucleus as  early 
as  5  minutes and  evident concentration over nu- 
cleolar areas at  15 minutes (Figs.  1 and 3). About 
28  per cent of thc nuclcar uptake of lysine  (Figs. 
1 and 2 and Table  I)  and RNA precursors (Figs. 
1 and  2)  is concentrated in the nucleolus, a  pro- 
portion 2.29 timcs  5 in excess of the nuclear uptake 
per unit area.  Lysine incorporation in  nuclcoli is 
significantly smaller after removal  of ribonnclcic 
acid  or  total  nucleic  acids  either  by  a  Feulgen 
type hydrolysis, by hot trichloracctic acid extrac- 
tion  (Fig.  2  and  Table  I),  or  by  ribonuclcase 
digestion  (Fig.  2).  After trypsin digestion, which 
Uncorrected for/3-ray self-absorption. 
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TABLE  I 
Mean Grain Counts of 20 HeLa Cells Labeled with H 3 Lysine  (10 p.c/ml) for  15 Minutes and Exposed 26 Days 
Cytoplasm  Background 
Nuclcolus  Nucleus  (-~ back-  l/q 5  ram' 
Treatment after fixation  Nucleus  (--  background)  ground)  (nucleus) 
None 
Untreated 
0.2797  4-  0.0158  85.9  -4-  4.3  140.7  6.7 
[0.120]  ±  [0.006] 
HCI  04, 0,5  N  0.2782  4-  0.0126  105.2  4-  6.2  147.8  5.0 
[0.115]  ±  [0.010] 
HC10.2  N  0.2736  4-  0.0117  96.2  4-  6.6  126.0  2.9 
[0.129]  4-  [0.010] 
Average  0.2771  4-  0.0135  95.7  -4-  5.7  138.1  4.9 
[0.121]  ±  [0.OO8] 
HCI  1 N, 60°C,  10  min.  (Feulgen)  0.1261  4-  0.0065  88.2  4-  4.7  138.8  10.5 
Trypsin 0.5  mg/ml 0°C,  30 min.  0.1552  4-  0.0087  90.1  :E  5.2  137.7  11.4 
TCA 0.3  N, 90°C  0.1133  -4-  0.0060  109.0  4-  8.0  130.4  5.7 
Actinomycin D, 0.05 #g/ml,  3  hrs., followed by maintenance medium, 3  hrs. 
None  0.1252  4-  0.0067  113.9  4-  8.4  155.6  4.7 
[0.107]  4-  [0.008] 
HC1  1 N 60°C,  10 min.  (Feulgen)  0.1252  4-  0.0101  84.5  4-  5.2  116.0  7.3 
Trypsin  0.1230  4-  0.0058  73.5  :E  3.4  147.8  8.6 
TCA 0.3  3, 90°C  0.1122  -4-  0.0056  133.1  -4-  7.6  154.2  6.0 
Numbers  in brackets  are ratio  of nucleolar  to nuclear  volume projected as rectangles. 
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bonds (21), the grain count per unit area is equiva- 
lent  for  nucleolus  and  nucleus  (Table  I).  The 
extent  of  nucleolar  lysine  incorporation  is  not 
reduced  by extraction and partial hydrolysis with 
0.5  N  perchloric  acid  (Fig.  2  and  Table  I),  0.2 
N  hydrochloric  acid  (Table  I)  or  by  enzymatic 
digestion with desoxyribonuclease (Fig.  2). 
Evidence that a  portion of the nucleolar lysine 
incorporation may be chemically and kinetically 
associated  with  a  rapidly  labeled  RNA  fraction 
was  obtained  by pretreatment  with  low  concen- 
Fmuns 3  Autoradiograph, Ha-lysine  (10 #c/ml,  15 minutes), HeLa cells, untreated.  Note  numerous 
silver grains over nucleoli, )< 1050. 
FmVRE 4  As above, pretreatment with Actinomycin D  (0.05 gg/ml).  Note  sparse  silver grains over 
nucleoli, but labeling over chromatin and cytoplasm. )< 1050. 
FIGURE 5  Autoradiograph, Ha-uridine (10/~c/ml, 15 minutes), untreated. X  1050. 
FIGURE 6  As above, pretreatment with Actinomycin  D. Note selective inhibition  of uptake over nucleoli. 
X  1050. 
312  B  R  I  E  F  N  O  T  S  S FIGURE 7.  Biebrieh scarlet,  phase.  Note intensely stained granules in nucleoli surrounded by lighter 
stained pars amorpha.  >(  1~00. 
FIGURE 8  As above, transmitted. Note granules associated with prometaphase chromosomes.  )<  1050. 
trations of Actinomycin D  (Figs.  1,  4,  and 6  and 
Table I). 
As shown in Figs.  1, 3 to 6, cells incubated with 
lysine  in  parallel  with  It3-uridine  show  a  con- 
comitant depression of nucleolar grain count when 
pretreated  with actinomycin at  concentrations of 
0.05  /~g/ml.  The  proportion  of  nucleolar  lysine 
uptake is reduced from 27.7 per cent of the total 
nuclear uptake  in untreated controls  to  12.5  per 
cent  (a  >  0.001)  in  actinomycin-pretreated cells 
(Table  I).  This  level  is  not  significantly higher 
than the ratio of the area of nucleolus to nucleus 
and  corresponds  to  the  proportional  uptake  ob- 
tained  after  nucleic acid  extraction  of untreated 
cells.  It  could  be  interpreted  both  as  nucleolar 
and  as  chromatin  label overlying the  nucleolus, 
an  interpretation supported  by  the  fact  that  nc 
further  reduction  of  lysine  incorporation  into 
nucleoli was observed after nucleic acid extraction 
or  weak  trypsin digestion of actinomycin-treated 
ceils.  Grain counts over  the  extranucleolar chro- 
matin of both  lysine and  uridine  (Fig.  1)  fail to 
show a  decrease at concentrations below 1 #g/ml. 
Similar observations with H3-uridine and H3-cyt  - 
idine have been previously reported by Perry (13). 
The cytoplasmic lysine uptake is not significantly 
affected by actinomycin in this dosage  (Table I). 
The  morphologic  localization  of  this  rapidly 
labeled,  lysine-containing  ribonucleoprotein  in 
nucleoli was  sought by parallel staining with the 
acid  dye  Biebrich  scarlet  at  pH  9.5  for  which 
Spicer  has  adduced  histochemical  and  spectro- 
photometric  evidence  of  specificity  for  e-amino 
groups of polylysine (14,  15).  Selective staining of 
nucleoli was obtained for HeLa cells after fixation 
and  partial  deamination  for  30  minutes  at  0°C 
with  3.7  per  cent  formaldehyde  buffered  at  pH 
7.3  in Millonig's phosphate  buffer  (18).  Nucleoli 
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stained granules or beaded  filaments, surrounded 
by  lighter  stained  areas  (Fig.  7).  With  the  dis- 
appearance  of  nucleoli  during  prophase  these 
granules  appear  in  the  nucleoplasm  associated 
with  chromosomes  (Fig.  8)  and  reappear  in  the 
nucleoli during telophase. Ribonuclease treatment 
in  these  experiments,  while  not  removing  acid- 
ophilia of nucleoli, results in prominent vacuola- 
tion  (Fig.  9).  Similar  vacuolation  is  seen  after 
FIGURE 9  Biebrieh scarlet, phase.  HeLa cells digested with ribonuelease.  Note prominent vacuoles  in 
nucleoli. )< 1050. 
FmvaE 10  As above, after Feulgen hydrolysis.  X  1050. 
FIGURE 11  Effect  of Actinomycin D,  Biebrich 
scarlet, transmitted. Note lack of granular sub- 
structure of nucleoli and margination by weakly 
stained areas ( ~ ).  Chromatin  granules  ( ~ ). 
X  1050. 
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acid  extraction,  whereas  trypsin  digestion  also 
reduces nucleolar staining. The nucleolar granules 
appear  resistant  to  DNase  digestion,  although 
some vacuolation is noted. Actinomycin treatment 
results in reorganization and ultimate disintegra- 
tion  of  nucleoli.  Stained  with  Biebrich  scarlet, 
nucleoli of cells  so  treated  have  an  amorphous 
appearance. Faintly stained areas often marginate 
the  nucleolus as  nucleoli diminish in  size. Con- 
comitantly, extranucleolar granules become pro- 
gressively  more  numerous  (Fig.  11). These  ob- 
servations suggest that the nucleolar granules may 
be a morphologic site of lysine incorporation. 
Similar  morphologic  observations  in  actino- 
mycin-treated cells have been made by Reynolds 
(23) and Clark (24). The Biebrich scarlet-reactive 
granules  appear  to  resemble  morphologically 
structures  described  in  various  studies  with  the 
light  and  electron  microscopes  (25-29).  They 
vary in size and their demonstration depends on 
selective  conditions of fixation. Their relationship 
to  "nucleolar chromatin"  (29)  or  to  nucleolone- 
mata and their function in nucleic acid and pro- 
tein synthesis must await further cytochemical and 
autoradiographic characterization with the aid of 
the electron microscope. 6 
DISCUSSION 
In the present study nucleolar granules contain- 
ing basic protein, stained with the acid dye Bie- 
brich  scarlet  at  strongly alkaline pH,  were  ob- 
served in apparent association with rapidly labeled 
RNA precursors and lysine and are not observed 
or are severely altered under conditions of RNA 
extraction.  Pretreatment  with  Actinomycin  D 
resulted  in inhibition of nucleolar lysine uptake 
but in continued uptake in chromatin and cyto- 
plasm and in a loss of distinctive nucleolar granu- 
lation.  As  a  working  hypothesis  it  is  suggested 
that  these  nucleolar structures may include sites 
of nuclear ribosomes or  ribosomal precursor  in- 
volving synthesis of ribonucleoprotein (3, 4, 6, 30). 
Observations seemingly contrary to these find- 
ings and to such a hypothesis have, however, been 
reported  by  Errera  et  al.  (22)  in  studies  with 
ultraviolet-irradiated nucleoli. These authors have 
failed  to  demonstrate  a  significant reduction  of 
amino  acid  uptake  in  nuclcoli when  nucleolar 
Since this paper was submitted such a study has 
been reported  by Schoefl, G.  I.,  J.  Ultrastruct.  Re- 
search, 1964, 10, 224. 
RNA synthesis was inhibited about 90  per cent. 
The  proportional  uptake  of  lysine  in  nucleoli 
relative to nuclei in controls of these experiments 
appears  to be,  however, considerably below that 
observed  in the  present experiments,  suggesting 
that perhaps some soluble peptides were lost under 
different conditions of fixation  (31,  32),  or  that 
possible  differences in growth  phase  of cells  (8), 
as  well as  differences of action of the  inhibitory 
agents  employed,  might  perhaps  account  for 
seeming discrepancies. An alternative interpreta- 
tion might assume that the reduced incorporation 
of  both  nucleic  acid  and  protein  precursors  is 
secondary to a  general disintegration of the  nu- 
cleolus  following  actinomycin  treatment.  This, 
however, would appear less likely in view of the 
late occurrence of such disintegration, the  rapid 
biochemical  effect  of  actinomycin in  inhibiting 
DNA-directed  RNA  synthesis  (34),  and  the  re- 
ported  observation  that  lysine  incorporation  in 
nucleoli is reduced under conditions of RNA ex- 
traction  and  trypsin  digestion  in  control  cells, 
but not in actinomycin-treated cells.  Such a  hy- 
pothesis  would also presuppose that early altera- 
tions in the morphology of the nucleolus (23,  24) 
are  independent of observed  biochemical effects 
of actinomycin. The  loss of lysine incorporation 
after  ribonuclease treatment and acid  hydrolysis 
could  be  due  to  soluble  or  nascent  polylysine 
peptide  chains  thought  to  be  linked  by  ester 
linkage  to  transfer  RNA  and  non-specifically 
bound to ribosomes (32). Hydrolytic or enzymatic 
removal of RNA,  or  fixation at  suboptimal pH 
or ionic strength would then result in solubiliza- 
tion  of  these  peptide  chains  in  aqueous  media. 
In  preliminary experiments  similar observations 
to those reported here were noted under conditions 
of  pulse  labeling; further  experiments to  clarify 
the extent of protein or amino acid labeling in the 
nucleolus are in progress.  A direct incorporation of 
lysine label into nucleotides via  the glycine path- 
way would appear unlikely. 
The continued lysine uptake in chromatin and 
cytoplasm in actinomycin-treated cells  (4,  33)  in 
the  absence  of  nucleolar  uptake  supports  the 
conclusion (8,  13)  that  at  least  some  nucleolar 
protein and RNA is synthesized independently of 
chromosomal  RNA  in  growing  cells  of  human 
origin. It would seem that Actinomycin D  at the 
concentration  used  may  permit  differentiation 
and localization of two types of lysine-containing 
B  R  I  E  F  N  0  T  E  ~  315 protein  or polypeptides; one which appears  to be 
localized  only in  the  nucleolus  and  which  is  re- 
moved  under  conditions  of RNA  extraction  and 
linked  metabolically  or  chemically  to  it  and,  a 
second found in the nucleus and cytoplasm, which 
is not removed under  conditions of RNA extrac- 
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